Pregabalin Capsule
Product Images NDC 68788-7521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 68788-7521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pregabalin Caps 50mg 30s Count

Pregabalin Caps 50mg 30s Count
The text appears to be a product label for Pregabalin Capsules in 50mg strength, which is a generic version of the drug Lyrica. It warns that the transfer of the capsules to anyone other than the person for whom they were prescribed is prohibited by federal law. The label provides information on the manufacturer (ScieGen Pharmaceuticals, Inc.) and the batch number. It also includes details about the contents of the capsules, the date of production, and the expiration date.*
FDA Label Image

Figure 1 (Pregabalin Fig01)

Figure 1 (Pregabalin Fig01)
FDA Label Image

Figure 2 (Pregabalin Fig02)

Figure 2 (Pregabalin Fig02)
FDA Label Image

Figure 3 (Pregabalin Fig03)

Figure 3 (Pregabalin Fig03)
FDA Label Image

Figure 4 (Pregabalin Fig04)

Figure 4 (Pregabalin Fig04)
FDA Label Image

Figure 5 (Pregabalin Fig05)

Figure 5 (Pregabalin Fig05)
FDA Label Image

Figure 6 (Pregabalin Fig06)

Figure 6 (Pregabalin Fig06)
The text describes the results of multiple studies involving the administration of various dosages of a drug (up to 600mg/day) compared to a placebo. The results indicate that the drug displayed statistically significant effects when compared to the placebo. However, it is difficult to determine the drug's name and the specific outcomes without additional information.*
FDA Label Image

Figure 7 (Pregabalin Fig07)

Figure 7 (Pregabalin Fig07)
FDA Label Image

Figure 9 (Pregabalin Fig08)

Figure 9 (Pregabalin Fig08)
FDA Label Image

Figure 10 (Pregabalin Fig09)

Figure 10 (Pregabalin Fig09)
FDA Label Image

Figure 11 (Pregabalin Fig10)

Figure 11 (Pregabalin Fig10)
FDA Label Image

Figure 12 (Pregabalin Fig11)

Figure 12 (Pregabalin Fig11)
Possible Description: This text presents a heading or title indicating a measure related to the percentage of subjects who improved. The subsequent text appears to show values ranging from 0 to 100, possibly indicating the level of improvement. A reference to "Bassine" and "Week 16" may suggest a time frame or context for the evaluation. However, the meaning and relevance of the text are unclear without additional information.*
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

Cockcroft And Gault Equation (Pregabalin Formula)
This is a formula used to calculate the creatinine clearance rate (CLCT) for patients, which is a measure of how well their kidneys are functioning. The formula takes into account the patient's age, weight, and serum creatinine level. For female patients, the age factor is multiplied by 0.85.*
FDA Label Image

Chemical Structure (Pregabalin Str)

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.